MILLENNIUM MANAGEMENT LLC - ELIEM THERAPEUTICS INC ownership

ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 20 filers reported holding ELIEM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of ELIEM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$154,007
-15.3%
58,336
-10.2%
0.00%
Q2 2023$181,807
+92658.7%
64,931
-4.0%
0.00%
Q1 2023$196
-19.0%
67,621
-0.1%
0.00%
Q4 2022$242
-99.9%
67,685
-6.1%
0.00%
Q3 2022$233,000
-14.3%
72,065
-19.9%
0.00%
Q2 2022$272,000
-79.0%
89,944
+25.0%
0.00%
-100.0%
Q3 2021$1,294,00071,9830.00%
Other shareholders
ELIEM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,938,263$5,097,6324.68%
RA Capital Management 13,150,849$34,586,7330.68%
SILVERARC CAPITAL MANAGEMENT, LLC 121,110$318,5190.10%
Atom Investors LP 78,886$207,4700.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 811,680$2,134,7180.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 55,223$145,7890.00%
Chicago Partners Investment Group LLC 12,806$32,7850.00%
TUDOR INVESTMENT CORP ET AL 29,704$78,1220.00%
NORTHERN TRUST CORP 11,182$29,4090.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ELIEM THERAPEUTICS INC shareholders